Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05309590 · ClinicalTrials.gov registry record

Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children

A clinical trial of Eosinophilic Esophagitis, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Active
Registry status
50
Enrollment target
1
Study location

NCT05309590 is a study of Eosinophilic Esophagitis that is active but no longer recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 50 participants, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05309590, a study of Eosinophilic Esophagitis, is active but no longer recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

ACTIVE NOT RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the decrease in steroid dosing for patients who have achieved remission on a full dose of steroids. Once a patient is in remission they will be enrolled in this study if they choose to decrease the steroid dosing.

Conditions Studied

Interventions

  • DRUG Dose

Study Locations (1)

Illinois

  • Ann & Robert H Lurie Childjren's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-05
Est. Completion 2027-11

What the Registry Record Tells You About NCT05309590

The ClinicalTrials.gov registry entry for NCT05309590 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which Dose is the first listed.

NCT05309590 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05309590 about?

NCT05309590 is a clinical study titled "Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children". This study evaluates the decrease in steroid dosing for patients who have achieved remission on a full dose of steroids. Once a patient is in remission they will be enrolled in this study if they choose to decrease the steroid dosing.

What is the current status of trial NCT05309590?

This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2014-05. Estimated completion is 2027-11.

What conditions does trial NCT05309590 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

What interventions are being tested in trial NCT05309590?

The interventions under investigation include: Dose (DRUG).

Who is sponsoring clinical trial NCT05309590?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05309590 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.